Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
heartflow
Overview
HeartFlow, Inc. is a pioneering medical technology company in the cardiovascular diagnostics space, specializing in the non-invasive assessment of coronary artery disease (CAD). Utilizing advanced computational fluid dynamics (CFD) and artificial intelligence (AI), HeartFlow's flagship product, the HeartFlow FFRct Analysis, generates a personalized 3D model of a patient's coronary arteries to determine the functional impact of blockages. This provides physicians with critical information to guide treatment decisions, potentially reducing the need for invasive procedures like cardiac catheterization and ultimately improving patient outcomes. HeartFlow has established itself as a key innovator in the field, driving the adoption of precision medicine in cardiology and competing with traditional diagnostic methods by offering a less invasive, more informative alternative.
heartflow's headcount breakdown by department
| Department | HeadCount |
|---|---|
Administrative | 4 |
Consulting | 1 |
Service | 10 |
Design | 1 |
Education | 7 |
HeartFlow's departmental composition clearly reflects its identity as a technology-driven medical device company heavily invested in research, sales, and product development. The robust 'Research' department (106 employees) highlights a strong commitment to innovation and ongoing refinement of its core technology, the FFRct Analysis. Coupled with a significant 'Technical' department (63 employees), this underscores the company's reliance on cutting-edge software and engineering capabilities. The large 'Sales' team (97 employees) indicates an aggressive strategy for market penetration and commercial adoption of HeartFlow's product within the medical community, necessitating a strong sales force to educate physicians and secure hospital contracts. The 'Other Department' category (89 employees), representing a substantial portion of the workforce, likely encompasses crucial functions such as regulatory affairs, quality assurance, clinical operations, and reimbursement specialists, all essential for navigating the complex healthcare landscape. The presence of a 'Medical' team (19 employees) demonstrates a focus on clinical validation and ensuring the accurate interpretation and application of the HeartFlow FFRct Analysis. Support functions like 'Finance' (13), 'HR' (7), 'Legal' (9), and 'Marketing' (9) are appropriately sized to support the company's core business activities. The relatively smaller numbers in departments like 'Customer Service' (10), 'Education' (7), 'Project Management' (17), and 'Operations' (12), suggest a scalable business model possibly utilizing external partnerships or efficient internal processes. The minimal investment in areas like 'Consulting' (1) and 'Design' (1) potentially indicate reliance on external expertise in these specialized areas or a highly focused and integrated approach within existing teams. Overall, the departmental distribution highlights a strategic balance between innovation, commercialization, and regulatory compliance, characteristic of a high-growth medical device company disrupting the traditional diagnostic market.
heartflow's employees by locations
Employee Count by Country
Total: 492 employees
HeartFlow's geographic footprint is predominantly concentrated in the United States (470 employees), which serves as its primary market and operational headquarters. This domestic focus reflects the company's origins and the initial adoption of its technology within the US healthcare system. A notable presence in the United Kingdom (12 employees) signals a strategic commitment to expanding into the European market, likely driven by favorable regulatory pathways and a growing demand for advanced diagnostic tools. Smaller teams strategically positioned in other European countries, including Italy, Belgium, Germany, and the Netherlands (1 employee each), suggest an exploratory phase, potentially involving key opinion leader engagement, market research, or initial sales efforts to lay the groundwork for broader adoption. The presence in Japan (3 employees) demonstrates an early foray into the Asian market, reflecting a potential interest in leveraging the country's advanced healthcare infrastructure and aging population. The presence of a small team in Canada (3 employees) indicates a natural expansion within the North American market, leveraging existing relationships and regulatory similarities. While not a globally dispersed organization, HeartFlow's targeted international presence aligns with its business model, which requires establishing strong relationships with healthcare providers, securing regulatory approvals, and navigating reimbursement pathways in each target market. This phased approach to international expansion allows HeartFlow to carefully manage resources and adapt its strategies to the specific needs and nuances of each region, prioritizing markets with significant potential and supportive healthcare ecosystems.
Want to stay ahead of heartflow's org changes?
Get alerts when hiring spikes or teams shift focus
Track changes vs. competitors
Spot warm GTM signals early